Antonetti Capital Management’s Pfizer PFE Stock Holding History

Antonetti Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$91.1K	Buy	2,747 +5	+0.2%	+$177	0.14%	68
2023 Q2	$101K	Buy	2,742 +4	+0.1%	+$156	0.14%	63
2023 Q1	$112K	Sell	2,738 -605	-18%	-$26.1K	0.16%	55
2022 Q4	$171K	Sell	3,343 -297	-8%	-$14.2K	0.23%	51
2022 Q3	$159K	Buy	3,640 +4	+0.1%	+$194	0.18%	49
2022 Q2	$191K	Sell	3,636 -191	-5%	-$9.73K	0.2%	48
2022 Q1	$198K	Sell	3,827 -996	-21%	-$51.7K	0.19%	55
2021 Q4	$285K	Sell	4,823 -757	-14%	-$37.5K	0.22%	67
2021 Q3	$240K	Buy	+5,580	New	+$247K	0.2%	77
2014 Q3	–	Sell	-422	Closed	-$12K	–	184
2014 Q2	$12K	Hold	422	–	–	0.01%	150
2014 Q1	$13K	Sell	422 -1	-0.2%	-$30	0.01%	161
2013 Q4	$12K	Buy	423 +1	+0.2%	+$29	0.01%	180
2013 Q3	$11K	Hold	422	–	–	0.01%	217
2013 Q2	$11K	Buy	+422	New	+$11.7K	0.01%	234

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Antonetti Capital Management's PFE Position: Q3 2023 in Review

Antonetti Capital Management increased its Pfizer (PFE) stake by 0.18% in Q3 2023, buying an estimated $177 and bringing the position to 2,747 shares worth $91.1K. The position accounts for 0.14% of the portfolio, ranked #68.

Antonetti Capital Management first reported a position in PFE in Q2 2013 and has held it in 14 quarters since. The position peaked at $285K in Q4 2021. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Antonetti Capital Management held 2,747 shares of Pfizer worth $91.1K as of Q3 2023.
Antonetti Capital Management bought 5 Pfizer shares in Q3 2023, an estimated $177.
Pfizer made up 0.14% of Antonetti Capital Management's portfolio in Q3 2023, its #68 holding.
Antonetti Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 14 quarters since.
Antonetti Capital Management's Pfizer position peaked at $285K in Q4 2021.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Antonetti Capital Management's 13F filing for Q3 2023, filed 9 Nov 2023.